STOCK TITAN

Aptera Motors agrees to roughly $6M stock offering

The deal pairs a registered share sale with privately placed warrants and sets temporary issuance limits and purchaser participation rights in later financings.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Aptera Motors Corp. (SEV) agreed to sell 3,428,571 Class B common shares at $1.75 per share in a registered direct offering and issue private warrants for up to 3,428,571 additional shares. The warrants have a $2.05 exercise price and a five-and-one-half-year term from initial exercise; stockholders approved their issuance on November 10, 2026, making them exercisable upon issuance.

Expected proceeds are approximately $6 million gross and approximately $5.5 million net after placement-agent fees and other estimated expenses; the net estimate excludes warrant-exercise proceeds. Closing is expected on or about November 12, 2026, subject to customary conditions, while the accompanying press release states November 11, 2026. The company will pay a 7.0% cash fee and reimburse reasonable, documented placement-agent expenses up to $65,000.

For 60 days after closing, the agreement restricts specified share and securities issuances and registration filings, subject to exceptions; variable-rate transactions are restricted for 180 days, subject to exceptions. After the 60th day, the company may sell shares under its existing at-the-market program and equity line. Purchasers may participate in up to 50% of subsequent financings through one year after closing, subject to exceptions.

Filing Explained

The added placement-agent warrants create potential further dilution, while the separate July warrant exercise resulted in 2,767,500 shares.

The offering remains awaiting its expected closing; separately, the placement-agency agreement adds warrants for up to 102,857 Class B shares, which would increase the share count if exercised.

The written consent also ratified the July 2026 warrant inducement: holders exercised warrants for 2,767,500 shares at $2.07 and received new warrants for up to 4,151,250 shares at $2.25.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Registered direct offering shares 3,428,571 Class B common shares Offered at $1.75 per share
Offering price $1.75 per share Registered direct offering
Private warrant shares Up to 3,428,571 shares Shares issuable upon exercise
Private warrant exercise price $2.05 per share Exercise price for each private warrant share
Expected gross proceeds Approximately $6 million Before placement-agent fees and estimated offering expenses
Expected net proceeds Approximately $5.5 million Excludes any net proceeds from exercise of private warrants
Placement-agent cash fee 7.0% of gross proceeds received Placement Agency Agreement
Placement-agent expense reimbursement Up to $65,000 Reasonable and documented out-of-pocket expenses
registered direct offering financial
"in a registered direct offering (the “Registered Direct Offering”)"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
cashless basis financial
"may only be exercised on a cashless basis if there is no effective registration statement"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
variable rate transaction financial
"any issuance of Common Stock or any securities ... involving a variable rate transaction"
Black Scholes Value financial
"the right to receive the Black Scholes Value calculated pursuant to a formula"
The Black–Scholes value is the theoretical fair price of a stock option calculated by the Black–Scholes mathematical model; it combines the current stock price, the option’s strike price, time until expiration, expected price swings (volatility), and interest rates to produce a single number. Investors use it like a reference sticker price: to spot mispriced options, guide trading and hedging decisions, and estimate potential risk and reward without relying on emotion or guesswork.
Subsequent Financing financial
"upon any issuance or incurrence ... of Common Stock, Common Stock equivalents, preferred stock, indebtedness"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SEV shares is Aptera selling, and at what price?

Aptera agreed to sell 3,428,571 Class B common shares at $1.75 per share in the registered direct offering. It also agreed to issue private warrants exercisable for up to 3,428,571 additional shares.

How much does Aptera expect to raise in the SEV offering?

Aptera expects approximately $6 million in gross proceeds and approximately $5.5 million in net proceeds after fees and other estimated expenses; the net estimate excludes proceeds from warrant exercises. Closing is expected on or about November 12, 2026, subject to customary conditions, while the accompanying press release states November 11, 2026.

What are the terms of Aptera's private warrants?

The private warrants cover up to 3,428,571 shares, have a $2.05 per-share exercise price, and expire five and one-half years from the initial exercise date. They become exercisable upon issuance after stockholder approval, which was obtained November 10, 2026. Exercise is limited if a holder's beneficial ownership would exceed 4.99%, or 9.99% at the holder's election.

Can purchasers take part in Aptera's later financings?

Purchasers have the right to participate, in aggregate, in up to 50% of a subsequent financing on the same terms, from the agreement date through one year after closing. The right has exceptions, including exempt issuances and issuances under the company's existing at-the-market program and equity line.

When will Aptera register the private warrant shares for resale?

Aptera agreed to file a resale registration statement as soon as practicable and within 60 calendar days of November 10, 2026. It will use commercially reasonable efforts to have the statement effective within 90 days after closing, or within 120 days if the SEC conducts a full review.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001786471 0001786471 2026-11-10 2026-11-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 10, 2026

 

APTERA MOTORS CORP.

(Exact name of Registrant as Specified in Its Charter)

 

Delaware   001-42884   83-4079594
(State or Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)

 

5818 El Camino Real    
Carlsbad, California   92008
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (858) 371-3151

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class B Common Stock, par value $0.0001 per share   SEV   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

The Offering

 

On November 10, 2026, Aptera Motors Corp. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors named therein (the “Purchasers”) pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 3,428,571 shares (the “Shares”) of its Class B common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $1.75 per share.

 

Pursuant to the Purchase Agreement, in a concurrent private placement (the “Private Placement” and together with the Registered Direct Offering, the “Offering”), the Company agreed to issue to the Purchasers warrants (the “Private Warrants”) exercisable for up to an aggregate of 3,428,571 shares of Common Stock (the “Private Warrant Shares”).

 

The Offering is expected to close on or about November 12, 2026, subject to the satisfaction of customary closing conditions.

 

The net proceeds of the Offering, after deducting the placement agent’s fees and expenses and other estimated expenses payable by the Company and excluding the net proceeds, if any, from the exercise of the Private Warrants, are expected to be approximately $5.5 million.

 

In the Purchase Agreement, the Company has agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock or file any registration statement or prospectus, or any amendment or supplement thereto, from the date of the Purchase Agreement until 60 days after the closing date of the Offering, subject to certain exceptions. In addition, the Company has agreed not to effect or enter into an agreement to effect any issuance of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock involving a variable rate transaction (as defined in the Purchase Agreement) until 180 days after the closing date of the Offering, subject to certain exceptions, provided that, following the 60th day after the closing date of the Offering, the Company may sell shares of Common Stock pursuant to its existing at the market offering program and its existing equity line of credit.

 

Pursuant to the Purchase Agreement, from the date of the Purchase Agreement until the date that is one year after the closing date of the Offering, upon any issuance or incurrence by the Company or any of its subsidiaries of Common Stock, Common Stock equivalents, preferred stock, indebtedness or a combination thereof (a “Subsequent Financing”), the Purchasers will have the right to participate, in the aggregate, in up to 50% of such Subsequent Financing on the same terms, conditions and price provided for in the Subsequent Financing, with such participation allocated among participating Purchasers on a pro rata basis if oversubscribed. The participation right is subject to certain exceptions, including for exempt issuances (as defined in the Purchase Agreement) and for issuances pursuant to the Company’s at-the-market offering program and equity line of credit.

 

Pursuant to the Purchase Agreement, the Company agreed to seek approval of the issuance of the Private Warrants and the Private Warrant Shares as required by applicable Nasdaq rules (the “Stockholder Approval”). On November 10, 2026, the Company obtained the Stockholder Approval by written consent of the holders of a majority of the outstanding shares of the Company’s Class A common stock, as described in Item 5.07 of this Current Report on Form 8-K.

 

The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the purchaser, including for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Purchase Agreement were made only for the purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties.

 

 

 

 

The Shares were offered pursuant to the Company’s effective Registration Statement on Form S-3 (Registration No. 333-299238), including a prospectus contained therein dated October 9, 2026, as supplemented by a prospectus supplement, dated as of November 10, 2026, relating to the Registered Direct Offering.

 

The form of the Purchase Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K. The foregoing summary of the terms of the Purchase Agreement is subject to, and qualified in its entirety by, the form of such document, which is incorporated herein by reference.

 

Terms of the Private Warrants

 

Each Private Warrant is exercisable for one share of Common Stock at an exercise price of $2.05 per share. The Company received the Stockholder Approval on November 10, 2026 (the “Stockholder Approval Date”). Accordingly, the Private Warrants will be exercisable immediately upon issuance, and will expire five and one-half years from the initial exercise date. Pursuant to the terms of the Purchase Agreement, the Company agreed, as soon as practicable and in any event within 60 calendar days of the date of the Purchase Agreement, to file a registration statement on Form S-3 (or other appropriate form if the Company is not then S-3 eligible) providing for the resale by the holders of the Private Warrant Shares, to use commercially reasonable efforts to cause such registration statement to become effective within 90 days following the closing date of the Offering (or within 120 days following the closing date in case of “full review” of such registration statement by the Securities and Exchange Commission) and to keep such registration statement effective at all times until no Purchaser owns any Private Warrants or Private Warrant Shares or such shares may be sold without restriction pursuant to Rule 144, subject to customary suspension periods.

 

Neither the issuance of the Private Warrants nor the Private Warrant Shares was registered under the Securities Act. The Private Warrants were offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and/or Rule 506(b) promulgated thereunder. The Private Warrants may only be exercised on a cashless basis if there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale of shares of Common Stock underlying the Private Warrants by the holder. The Company is prohibited from effecting an exercise of any Private Warrants to the extent that such exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.99% (or, at the election of the holder, 9.99%) of the total number of shares of Common Stock outstanding immediately after giving effect to the exercise, which percentage may be increased or decreased at the holder’s election not to exceed 9.99%, with any increase effective 61 days after notice to the Company. In the event of certain fundamental transactions, the holder of the Private Warrants will have the right to receive the Black Scholes Value calculated pursuant to a formula set forth in the Private Warrants, payable in cash or, if the fundamental transaction is not within the Company’s control, in the form of consideration as described in the Private Warrants.

 

The form of Private Warrant is filed as Exhibit 4.1 to this Current Report on Form 8-K. The foregoing summary of the terms of the Private Warrants is subject to, and qualified in its entirety by, the form of such document, which is incorporated herein by reference.

 

Placement Agent Compensation

 

Pursuant to a Placement Agency Agreement, dated November 10, 2026 (the “Placement Agency Agreement”), by and between the Company and Ladenburg Thalmann & Co. Inc. (the “Placement Agent”), the Placement Agent agreed to act as the lead placement agent, on a reasonable best efforts basis, in connection with the Offering. The Company agreed to pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds received in the Offering. The Company also agreed to reimburse the Placement Agent for its reasonable and documented out-of-pocket expenses up to $65,000 in the aggregate. The Placement Agency Agreement contains customary representations, warranties and covenants of the Company and customary conditions to closing, and the Company has agreed to indemnify the Placement Agent against certain liabilities, including liabilities under the Securities Act.

 

Also pursuant to the Placement Agency Agreement, the Company, in connection with the Offering, agreed to issue the Placement Agent or its designees warrants (the “Placement Agent Warrants”) to purchase up to an aggregate of 102,857 shares of Common Stock (the “Placement Agent Warrant Shares”). The Placement Agent Warrants will have substantially the same terms as the Private Warrants described above, except that the Placement Agent Warrants will have an exercise price of $2.1875 per share and will expire five years from the commencement of sales in the Offering. The Company has agreed to include the Placement Agent Warrant Shares in the resale registration statement covering the Private Warrant Shares.

 

 

 

 

The forms of Placement Agent Warrant and Placement Agency Agreement are filed as Exhibits 4.2 and 10.2, respectively, to this Current Report on Form 8-K. The foregoing summaries of the terms of the Placement Agent Warrants and the Placement Agency Agreement are subject to, and qualified in their entirety by, the forms of such documents, which are incorporated herein by reference.

 

The opinion of Lowenstein Sandler LLP regarding the validity of the Shares issued in the Registered Direct Offering is attached as Exhibit 5.1 hereto.

 

This Current Report on Form 8-K does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 above with respect to the Private Warrants, the Private Warrant Shares, the Placement Agent Warrants and the Placement Agent Warrant Shares is incorporated herein by reference to this Item 3.02.

  

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On November 10, 2026, the holders of a majority of the outstanding shares of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), which is the only class of the Company’s capital stock entitled to vote on the matters described below, acted by written consent in lieu of a meeting pursuant to Section 228 of the General Corporation Law of the State of Delaware (the “DGCL”) to approve, for purposes of Nasdaq Listing Rule 5635(d): (i) the issuance of the securities issued and issuable in the Offering, including the Shares, the Private Warrants, the Private Warrant Shares, the Placement Agent Warrants and the Placement Agent Warrant Shares; and (ii) the ratification and approval of the Company’s July 2026 warrant inducement transaction, pursuant to which holders of warrants issued by the Company on March 13, 2026 exercised such warrants for an aggregate of 2,767,500 shares of Common Stock at a reduced exercise price of $2.07 per share and the Company issued to such holders new unregistered warrants to purchase up to an aggregate of 4,151,250 shares of Common Stock at an exercise price of $2.25 per share, in each case whether considered alone or aggregated with the Offering. The written consent was executed by the holders of 10,000,000 shares of Class A Common Stock, representing approximately 83.5% of the outstanding shares of Class A Common Stock as of November 9, 2026, the record date fixed by the Company’s Board of Directors for the action.

 

Item 7.01. Regulation FD Disclosure.

 

On November 10, 2026, the Company issued a press release announcing the Offering. A copy of this press release is attached as Exhibit 99.1 hereto.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements that involve risks and uncertainties, such as statements other than historical facts, statements related to the amount of proceeds expected from the Offering, the expected closing conditions related to the Offering, and the intended use of proceeds. The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “will,” “plan,” and similar expressions are intended to identify forward-looking statements. The risks and uncertainties involved include the Company’s financial position, market conditions and other risks detailed from time to time in the Company’s periodic reports and other filings with the Commission. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company’s current expectations and assumptions and speak only as of the date of this Current Report on Form 8-K. The Company does not intend to revise or update any forward-looking statement in this Current Report on Form 8-K as a result of new information, future events or otherwise, except as required by law.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Number

  Description
     
4.1   Form of Private Warrant
     
4.2   Form of Placement Agent Warrant
   
5.1   Opinion of Lowenstein Sandler LLP
   
10.1   Form of Purchase Agreement
     
10.2   Placement Agency Agreement, dated November 10, 2026, by and between the Company and Ladenburg Thalmann & Co. Inc.
     
23.1   Consent of Lowenstein Sandler LLP (contained in Exhibit 5.1)
   
99.1   Press Release dated November 10, 2026
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Aptera Motors Corp.
     
  By: /s/ Tom DaPolito
  Name: Tom DaPolito
  Title: Interim Chief Financial Officer
     
Date: November 10, 2026    

 

 

 

 

Exhibit 99.1

 

Aptera Motors Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement

 

CARLSBAD, Calif., November 10, 2026 (GLOBE NEWSWIRE) — Aptera Motors Corp. (Nasdaq: SEV) (“Aptera” or the “Company”), a solar mobility company advancing ultra-efficient transportation, today announced that it has entered into a definitive securities purchase agreement with institutional investors for the purchase and sale of 3,428,571 shares of the Company’s Class B common stock at an offering price of $1.75 per share in a registered direct offering.

 

In addition, in a concurrent private placement, the Company will issue to the investors unregistered warrants to purchase up to 3,428,571 shares of Class B common stock in the aggregate. The warrants will have an exercise price of $2.05 per share, will be exercisable on or after stockholder approval, and will have a term of five and one half years from the initial exercise date.

 

The aggregate gross proceeds to the Company from the offerings are expected to be approximately $6 million before deducting placement agent fees and estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the offerings for general corporate purposes, ongoing product validation and manufacturing readiness activities, including vehicle validation testing, advancement of design-for-manufacturability and production planning efforts, initiation of production supplier engagements, and commencement of long-lead tooling in support of our production plans.

 

The closing of the registered direct offering and the concurrent private placement is expected to occur on or about November 11, 2026, subject to the satisfaction of customary closing conditions.

 

Ladenburg Thalmann & Co. Inc. is acting as lead placement agent for the offering. StoneX Financial Inc. is acting as co-placement agent.

 

The shares of Class B common stock are being offered under a shelf registration statement on Form S-3 (File No. 333-299238), which was declared effective by the United States Securities and Exchange Commission (“SEC”) on October 9, 2026. The registered direct offering is being made only by means of a prospectus, including a prospectus supplement, that forms part of the effective registration statement and will be filed with the SEC. When available, electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained on the SEC’s website at http://www.sec.gov or by contacting Ladenburg Thalmann & Co. Inc., Prospectus Department, 640 Fifth Avenue, 4th Floor, New York, New York 10019, or by email at prospectus@ladenburg.com, or StoneX Financial Inc., 230 Park Avenue, 32nd Floor, New York, New York 10169, or by email at prospectus@stonex.com.

 

The warrants and the shares of Class B common stock underlying them are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder. The warrants and underlying shares have not been registered under the Securities Act or applicable state securities laws. Accordingly, they may not be offered or sold in the United States except under an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and those state securities laws. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of Class B common stock issuable upon exercise of the warrants.

 

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described in it. There will be no sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of that state or jurisdiction.

 

 

 

 

About Aptera Motors Corp.

 

Aptera Motors Corp. (Nasdaq: SEV) is a solar mobility company driven by a mission to advance the future of efficient transportation. Its flagship vehicle is conceived to be a paradigm-shifting solar electric vehicle that leverages breakthroughs in aerodynamics, material science, and solar technology to pursue new levels of efficiency. As a public benefit corporation, Aptera is committed to building a sustainable business that positively impacts its stakeholders and the environment. Aptera is headquartered in Carlsbad, California. For more information, please visit www.aptera.us.

 

Forward-Looking Statements

 

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These include, but are not limited to, statements about: the completion, timing and size of the registered direct offering and the concurrent private placement; the satisfaction of customary closing conditions; the expected gross proceeds of the offering; the Company’s ability to obtain stockholder approval for the exercisability of the common warrants; and the filing and effectiveness of a resale registration statement.

 

These forward-looking statements were based on current expectations, estimates, forecasts and projections, as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “estimate,” “intend,” “may,” “will,” “could,” “plan,” “continue,” and variations or the negative of these terms and similar expressions are intended to identify forward-looking statements.

 

Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Aptera’s control. These risks include, among others: risks and uncertainties related to market and other conditions, and to the satisfaction of customary closing conditions for the offerings; the risk that the Company does not obtain stockholder approval for the exercisability of the warrants, in which case the warrants will not become exercisable and the Company will not receive any proceeds from their exercise; the Company’s broad discretion over the use of the net proceeds from the offerings; and the other risks described in Aptera’s Annual Report on Form 10-K for the year ended December 31, 2025, the prospectus supplement relating to the registered direct offering, and its other filings with the SEC.

 

The forward-looking statements in this press release represent Aptera’s views as of the date of this press release. Aptera undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing Aptera’s views as of any date after the date of this press release.

 

Investor Relations: Aptera Motors Corp. ir@aptera.us

 

Media Contact: media@aptera.us

 

 

 

Filing Exhibits & Attachments

10 documents

Keep reading